PedAM
Pediatric Disease Annotations & Medicines
| Disease | asthma |
| Phenotype | C0155877|allergic asthma |
| Sentences | 11 |
| PubMedID- 22745565 | In 2009 the licence was extended to include children aged 6 to <12 years as an add-on treatment for poorly controlled asthma in patients with severe persistent allergic asthma.59 in addition to the us and europe, omalizumab is licensed for treating patients with moderate to severe allergic asthma in a large number of other countries worldwide including australia, canada and brazil. |
| PubMedID- 22525394 | Omalizumab and asthma control in patients with moderate-to-severe allergic asthma: a 6-year pragmatic data review. |
| PubMedID- 20883456 | Previously, we reported that 3 years of sq-standardized hdm subcutaneous immunotherapy (scit) was generally well tolerated and partly replaced the need for ics treatment to control asthma in adults with hdm-allergic asthma; hdm scit had a steroid-sparing effect (12). |
| PubMedID- 23168918 | Conclusions: dermatophagoides pteronyssinus-induced early- and late-phase asthmatic response in patients with allergic asthma was found to be accompanied by an increased percentage of peripheral blood th17 cells and elevated serum il-17 levels as well as altered neutrophil functions. |
| PubMedID- 20384875 | To elucidate the kinetics and the regulation of scd14 concentrations in bal in asthma, 18 patients with allergic asthma underwent segmental allergen challenge at different time points (10 min, 18, 42 and 162 h). |
| PubMedID- 26557252 | Improved asthma control in patients with severe, persistent allergic asthma after 12 months of nightly temperature-controlled laminar airflow: an observational study with retrospective comparisons. |
| PubMedID- 24161744 | Methods: a total of 36 subjects were enrolled into the study: 15 allergic asthma patients with early asthmatic reaction (n=7) or dual asthmatic reaction (n=8) developed to inhaled d. |
| PubMedID- 26430389 | It is currently hypothesized that the use of blood eosinophils as biomarkers could help to personalize asthma management in patients with severe allergic asthma. |
| PubMedID- 22277052 | We evaluated the effect of omalizumab on asthma control in patients with persistent allergic asthma inadequately controlled with nhlbi step 4 or above asthma therapy. |
| PubMedID- 23672783 | Objective: our goal was to understand the mechanism of nonallergic asthma that leads to airway hyperreactivity (ahr), a cardinal feature of asthma independent of adaptive immunity. |
| PubMedID- 21354028 | Objectives: to determine whether treatment with montelukast would improve asthma disease control in patients with mild allergic asthma during an experimentally induced rhinovirus infection. |
Page: 1